Respiratory syncytial virus (RSV) is a global cause of severe respiratory morbidity and mortality in infants. While preventive and therapeutic interventions are being developed, including antivirals, vaccines and monoclonal antibodies, little is known about the global molecular epidemiology of RSV. INFORM is a prospective, multicenter, global clinical study performed by ReSViNET to investigate the worldwide molecular diversity of RSV isolates collected from children less than 5 years of age. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• June 2020

Hannah Christopher Samantha Minda Moore Blyth Carlson Sarna HC CC SC MS OAM BSc (Hons) GradDipClinEpi PhD MBBS (Hons) DCH FRACP FRCPA PhD BSc MPH PhD M.App.Epid., PhD Program Head, Infection and Vaccines Centre Head, Wesfarmers Centre of Vaccines ...

• Wesfarmers Centre of Vaccines & Infectious Diseases
• Our research
• Vaccine Trials Group
• Current studies

Christopher Blyth CC MBBS (Hons) DCH FRACP FRCPA PhD Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and Infectious Diseases, Honorary and NHMRC Emerging ...

• Telethon Kids Institute
• Projects

Christopher Jennifer Peter Blyth Kent Richmond CC J PC MBBS (Hons) DCH FRACP FRCPA PhD RN MBBS MRCP(UK) FRACP Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of ...

• Telethon Kids Institute
• Projects
• Past projects

This review supports the recommended use of palivizumab for reducing RSV-associated hospitalisation rates in premature babies born at gestational age <33 weeks. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2014
• January 2014

Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly. Non-pharmaceutical interventions and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory viruses including RSV globally, particularly in Australia, where during 2020 the normal winter epidemics were notably absent. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• May 2022

Hannah Moore HC OAM BSc (Hons) GradDipClinEpi PhD Program Head, Infection and Vaccines 08 6319 1427 Hannah.moore@telethonkids.org.au Program Head, Infection and Vaccines A/Prof Hannah Moore OAM is Program Head, Infections and Vaccines at the ...

• Telethon Kids Institute
• Projects

We develop a compartmental model for RSV infection, driven by a seasonal forcing function, and conduct parameter space and bifurcation analyses to document... ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2016
• January 2016

Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at ...

• Telethon Kids Institute
• Projects

Hannah Tom Moore Snelling HC T OAM BSc (Hons) GradDipClinEpi PhD BMBS DTMH GDipClinEpid PhD FRACP Program Head, Infection and Vaccines Head, Infectious Disease Implementation Research 08 6319 1427 08 6319 1817 Hannah.moore@telethonkids.org.au ...

• Telethon Kids Institute
• Projects

Hannah Peter Moore Richmond HC PC OAM BSc (Hons) GradDipClinEpi PhD MBBS MRCP(UK) FRACP Program Head, Infection and Vaccines Head, Vaccine Trials Group 08 6319 1427 Hannah.moore@telethonkids.org.au Program Head, Infection and Vaccines Head, Vaccine ...

• Telethon Kids Institute
• Projects

Whether vaccination during pregnancy could reduce the burden of respiratory syncytial virus (RSV)-associated lower respiratory tract illness in newborns and infants is uncertain. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• April 2023